Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis. Radiol Oncol. 2022;56(2):185-197. Accessed October 13, 2026. https://radioloncol.com/index.php/ro/article/view/3779